Chemical Structure : GZNL-P36
Catalog No.: PC-23545Not For Human Use, Lab Use Only.
GZNL-P36 is a potent, selective and orally bioavailable SARS-CoV-2 papain-like protease (PLpro) inhibitor with IC50 of 6.45 nM, ITC Kd value of 24.6 nM.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
GZNL-P36 is a potent, selective and orally bioavailable SARS-CoV-2 papain-like protease (PLpro) inhibitor with IC50 of 6.45 nM, ITC Kd value of 24.6 nM.
GZNL-P36 dose-dependently protects cells from death with 50% effective concentration (EC50) values for wild type (WT), Omicron BA.5 and XBB.1 is 111.0 nM, 306.2 nM and 58.2 nM, respectively.
GZNL-P36 possesses similar effective anti-viral activity for SARS-CoV-2 and its variants, compared with S-217622 (Ensitrelvir).
GZNL-P36 also exhibits anti-viral activity for the other coronaviruses, such as HCoV-NL63 (EC50: 81.6 nM) and HCoV-229E (EC50: 2.66 μM).
Oral administration of the GZNL-P36 results in significantly improved survival and notable reductions in lung viral loads and lesions in SARS-CoV-2 infection mouse model, consistent with RNA-seq data analysis.
M.Wt | 466.59 | |
Formula | C29H30N4O2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Lu Y, et al. Nat Commun. 2024 Nov 23;15(1):10169.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright